135 related articles for article (PubMed ID: 17539937)
1. Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features.
Romi F; Aarli JA; Gilhus NE
Eur J Neurol; 2007 Jun; 14(6):617-20. PubMed ID: 17539937
[TBL] [Abstract][Full Text] [Related]
2. Titin and ryanodine receptor antibodies in myasthenia gravis.
Skeie GO; Aarli JA; Gilhus NE
Acta Neurol Scand Suppl; 2006; 183():19-23. PubMed ID: 16637922
[TBL] [Abstract][Full Text] [Related]
3. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
Shelton GD; Skeie GO; Kass PH; Aarli JA
Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
[TBL] [Abstract][Full Text] [Related]
4. [Thymectomy and muscle antibodies in myasthenia gravis].
Romi F; Gilhus NE; Aarli JA
Tidsskr Nor Laegeforen; 2004 Mar; 124(5):629-31. PubMed ID: 15004605
[TBL] [Abstract][Full Text] [Related]
5. The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo.
Romi F; Kristoffersen EK; Aarli JA; Gilhus NE
J Neuroimmunol; 2005 Jan; 158(1-2):191-4. PubMed ID: 15589053
[TBL] [Abstract][Full Text] [Related]
6. Muscle autoantibodies in subgroups of myasthenia gravis patients.
Romi F; Skeie GO; Aarli JA; Gilhus NE
J Neurol; 2000 May; 247(5):369-75. PubMed ID: 10896269
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic myasthenia gravis: immunological and clinical aspects.
Skeie GO; Romi F
Eur J Neurol; 2008 Oct; 15(10):1029-33. PubMed ID: 18717725
[TBL] [Abstract][Full Text] [Related]
8. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
Romi F; Skeie GO; Aarli JA; Gilhus NE
Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients.
Hong Y; Li HF; Skeie GO; Romi F; Hao HJ; Zhang X; Gao X; Owe JF; Gilhus NE
J Neuroimmunol; 2016 Sep; 298():51-7. PubMed ID: 27609275
[TBL] [Abstract][Full Text] [Related]
10. Autoimmunity against the ryanodine receptor in myasthenia gravis.
Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
Acta Physiol Scand; 2001 Mar; 171(3):379-84. PubMed ID: 11412151
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies.
Skeie GO; Romi F; Aarli JA; Bentsen PT; Gilhus NE
Ann N Y Acad Sci; 2003 Sep; 998():343-50. PubMed ID: 14592894
[TBL] [Abstract][Full Text] [Related]
12. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis.
Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
Eur J Neurol; 2002 Jan; 9(1):55-61. PubMed ID: 11784377
[TBL] [Abstract][Full Text] [Related]
13. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
Mygland A; Aarli JA; Matre R; Gilhus NE
J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
[TBL] [Abstract][Full Text] [Related]
14. Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlations.
Romi F; Skeie GO; Vedeler C; Aarli JA; Zorzato F; Gilhus NE
J Neuroimmunol; 2000 Nov; 111(1-2):169-76. PubMed ID: 11063835
[TBL] [Abstract][Full Text] [Related]
15. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
Romi F; Skeie GO; Gilhus NE; Aarli JA
Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in acquired myasthenia gravis: Clinical phenotype and immunological correlation.
Nagappa M; Mahadevan A; Gangadhar Y; Patil SA; Bokolia S; Bindu PS; Sinha S; Taly AB
Acta Neurol Scand; 2019 May; 139(5):428-437. PubMed ID: 30693486
[TBL] [Abstract][Full Text] [Related]
17. Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis.
Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
Ann N Y Acad Sci; 2003 Sep; 998():481-90. PubMed ID: 14592917
[TBL] [Abstract][Full Text] [Related]
18. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.
Romi F; Bø L; Skeie GO; Myking A; Aarli JA; Gilhus NE
J Neuroimmunol; 2002 Jul; 128(1-2):82-9. PubMed ID: 12098514
[TBL] [Abstract][Full Text] [Related]
19. The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.
Chen XJ; Qiao J; Xiao BG; Lu CZ
J Neurol; 2004 Aug; 251(8):1006-11. PubMed ID: 15316806
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes.
Skeie GO; Pandey JP; Aarli JA; Gilhus NE
Autoimmunity; 1997; 26(2):111-6. PubMed ID: 9546812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]